Blue Trust Inc’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
DM
B
GS
Blue Trust Inc's CDNA Position: Q1 2026 in Review
Blue Trust Inc sold out of CareDx (CDNA) in Q1 2026, closing a stake of 1 share — an estimated $19 sold.
Blue Trust Inc first reported a position in CDNA in Q4 2022 and held it in 7 quarters. The position peaked at $9.98K in Q4 2024. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Blue Trust Inc reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
- Blue Trust Inc sold 1 CareDx share in Q1 2026, an estimated $19.
- Blue Trust Inc first reported a position in CareDx in Q4 2022 and held it in 7 quarters.
- Blue Trust Inc's CareDx position peaked at $9.98K in Q4 2024.
- 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.